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ABSTRACT: Host−microbe communication via small mole-
cule signals is important for both symbiotic and pathogenic
relationships, but is often poorly understood at the molecular
level. Under conditions of host stress, levels of the human
opioid peptide dynorphin are elevated, triggering virulence in
the opportunistic pathogenic bacterium Pseudomonas aeruginosa
via an unknown pathway. Here we apply a multilayered
chemical biology strategy to unravel the mode of action of this
putative interkingdom signal. We designed and applied
dynorphin-inspired photoaﬃnity probes to reveal the protein
targets of the peptide in live bacteria via chemical proteomics.
ParS, a largely uncharacterized membrane sensor of a two-
component system, was identiﬁed as the most promising hit.
Subsequent full proteome studies revealed that dynorphin(1−13) induces an antimicrobial peptide-like response in Pseudomonas,
with speciﬁc upregulation of membrane defense mechanisms. No such response was observed in a parS mutant, which was more
susceptible to dynorphin-induced toxicity. Thus, P. aeruginosa exploits the ParS sensing machinery to defend itself against the
host in response to dynorphin as a signal. This study highlights interkingdom communication as a potential essential strategy not
only for induction of P. aeruginosa virulence but also for maintaining viability in the hostile environment of the host.
■ INTRODUCTION
The dynorphins are important endogenous human peptide
hormones that act primarily through binding to the κ-opioid
receptor (OPRK) and have roles in pain response, stress, and
addiction, among others.1 Opioids and their receptors are
important components of the peripheral nervous system, but
they also accumulate during host stress at sites of
inﬂammation.2 Coupled with evidence that bacteria activate
virulence in response to host stress,3 these observations suggest
that opioids may be recognized by bacteria as signaling
molecules. A small molecule OPRK agonist and the peptide
hormone dynorphin-A (Dyn-A) were shown to activate
quorum sensing and result in enhanced virulence of the
opportunistic pathogen Pseudomonas aeruginosa (PA).4 PA is
one of the most commonly isolated microbes in patients with
bloodstream and lung infections in acute care settings in
Europe and the leading cause of death in patients with cystic
ﬁbrosis.5 The pathogen is also very challenging to treat due to
its high intrinsic resistance to antibiotics and its ability to
modulate its behavior in widely diﬀerent environments and in
response to a host. This ability may stem in part from the
organism’s large number of two-component sensors, its large
genome, and its complex quorum sensing networks.6 In a
rodent stress model, Dyn-A was shown to be released in the
intestine where it bound to and was taken up by bacteria.4 A
subsequent study showed that PA regulates its response to a
small molecule opioid depending on the abundance of nutrients
in the environment, integrating multiple inputs in the decision
to switch to the costly virulence phenotype.7 Bacteria have
receptors that recognize other host molecules (e.g., interferon-
γ8 and adrenergic hormones9). However, the putative
dynorphin receptor and the majority of the response circuitries
mediating bacterial response to opioids are completely
unknown (Figure 1a). Targeting virulence or manipulating
host−microbe or microbe−microbe communications have been
put forward as possible nontraditional approaches to tackle the
rise of multidrug-resistant bacteria. However, the pathways and
environmental conditions, such as host stress and interkingdom
signaling, that lead to microbial virulence are poorly explored.
Here, we use a chemical biology approach to unravel the
mechanism of action of the human opioid peptide Dyn-A in
PA. Phenotypic studies ﬁrst conﬁrm that the virulence-inducing
eﬀect of a truncated dynorphin analogue (DYN) is peptide
sequence dependent. We then employ a chemical proteomic
approach using DYN-inspired photoaﬃnity probes to identify
the membrane sensor ParS as a putative binding partner of
DYN in live bacteria. In-depth global proteomic analyses
further deﬁne the speciﬁc defense response evoked in PA by
DYN. Finally, we show that this defense response is abrogated
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in a mutant lacking ParS, functionally linking peptide binding to
ParS with the phenotypic response.
■ RESULTS
Dynorphin and Derivatives Induce Pseudomonas
Virulence. Since PA virulence is known to be highly
environment dependent, we ﬁrst sought to deﬁne the
conditions under which dynorphin induced a response.
Previous work has linked the peptide Dyn-A (dynorphin(1−
17)-OH) and the small molecule opioid U50,488 to induction
of virulence in PA strain PAO1.4,7 We conﬁrmed that in our
hands these compounds also induced the production of the
blue-green toxin pyocyanin under similar conditions of nutrient
limitation, as did a truncated Dyn-A analogue with a C-terminal
amide (DYN, dynorphin(1−13)-NH2; Figure S1). The N-
terminus of dynorphin is critical for signaling via human opioid
receptors, and this truncated peptide is equipotent in the
human system.10 However, although they induced a similar
response to each other, the two peptides behaved quite
diﬀerently compared to the small molecule: There was
signiﬁcant growth reduction at higher concentrations of peptide
and a corresponding drop-oﬀ of pyocyanin production, whereas
U50,488 was less toxic to bacteria and only induced pyocyanin
at higher concentrations (Figure S1). It is therefore not clear
that dynorphin-based peptides and U50,488 have the same
phenotype and thus mode of action. We decided to focus on
the endogenous peptide signals and, given the similar responses
of the two peptides, chose the shorter dynorphin analogue,
DYN, for synthetic tractability. We used a chemically deﬁned
MOPS-buﬀered succinate medium to optimize the iron and
phosphate contents, since these components are important for
the virulence responses of PA (Figure S1).7 Our optimized
conditions generated more reproducible data, and we observed
that DYN (Figure 1b) induced mild toxicity and production of
pyocyanin in a dose-dependent manner (Figure 1c).
To establish whether the sequence of DYN is important for
the observed phenotype, we tested a sequence-scrambled
peptide (SCR) and a charge-control peptide (CC), which has a
diﬀerent composition but is still highly basic (Figure 1b). The
charge control showed no signiﬁcant eﬀect on either growth or
virulence, and the scrambled peptide a greatly reduced eﬀect
(Figure 1d), suggesting a highly speciﬁc response to DYN.
Photoaﬃnity Proﬁling of Dynorphin Targets. Intrigued
by this phenotype, we next sought to identify protein
interacting partners of DYN in live bacteria using photoprobes.
Photoaﬃnity labeling is a technique used to explore small
molecule-protein binding.11,12 A chemical probe mimicking the
molecule of interest is equipped with a photoreactive group and
a label or tag for detection. The probe is incubated with lysates
or live cells, and, upon UV irradiation, a highly reactive
intermediate is generated from the photoreactive group which
cross-links the probe to its biomolecular binding partners
(Figure 2a). Common photoreactive groups include benzo-
phenone (Bpa), aryl azides (ArN3), and diazirines (Di) (Figure
2b), which possess diﬀerent photoproperties and steric
footprints.13 Given their distinct and complementary proper-
ties, it is diﬃcult to predict which photogroup will perform best
in any one system; therefore we investigated all three. Rather
than modify the peptide with a large label for detection, we
incorporated a terminal alkyne into the structure of probes; this
pretag allows subsequent attachment of a ﬂuorophore or biotin
aﬃnity label via copper-catalyzed azide−alkyne cycloaddition
(CuAAC) for enrichment and visualization (Figure 2a). Probes
were synthesized using Fmoc-SPPS chemistry. The bulkiest
photogroup, Bpa, was incorporated at two diﬀerent positions:
in place of phenylalanine (probe DYN1) and at the C-terminus
of the sequence (DYN3; Figure 2b).
Similarly, an aryl azide moiety was incorporated in place of
phenylalanine in DYN4 and diazirine-containing “photopro-
line”14 in place of proline in DYN5. A synthetically facile
orthogonal protection strategy also yielded probe DYN9, where
a short diazirine building block was coupled to a lysine side
chain. Probes DYN5, DYN4, DYN3, and DYN1 all triggered a
clear virulence response in PA, while the scrambled Bpa probe
SCR1 showed very little eﬀect, as anticipated (Figures 3a and
S2). Unexpectedly, DYN9 had little eﬀect on pyocyanin
production (Figure S2), possibly indicating high sequence
sensitivity of the virulence response.
To perform labeling experiments in live cells, PA was grown
to early stationary phase, resuspended in PBS, and incubated
with probes at 4 μM (the onset of virulence induction), and
samples were irradiated. Cells were washed and lysed, and
lysates subject to CuAAC to attach a rhodamine ﬂuorophore.
Figure 1. DYN induces virulence in Pseudomonas aeruginosa in a
sequence-speciﬁc manner. (a) Dynorphin is a human peptide hormone
released by host cells during stress. It triggers a virulence response in
the bacterium PA via an unknown pathway and putative receptor. (b)
Sequences of DYN and control peptides. (c) The eﬀect of DYN on
growth, as measured by optical density (OD, gray bars), and on the
production of the virulence factor pyocyanin (PYO, blue bars) in
PAO1. Error bars show standard deviation from three independent
biological experiments. OD and PYO were normalized to DMSO
control in each case. (d) Analyzing the sequence speciﬁcity of the
DYN response using the peptides shown in (b).
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Separation of proteins by SDS-PAGE and ﬂuorescence
scanning revealed some striking diﬀerences between probes
bearing diﬀerent photoreactive groups (Figure 3b). All probes
exhibited irradiation-dependent labeling, but while aryl azide
probe DYN4 labeled distinct bands, both diazirine and Bpa
probes additionally gave rise to diﬀuse bands and a “laddering”
pattern, reminiscent of heterogeneous glycolipids. Lipopoly-
saccharide (LPS) forms a large part of the surface coat of PA
and other Gram-negative bacteria and consists of lipid A, a core
oligosaccharide, and a variable O-antigen polysaccharide side
chain.15 Treatment of samples after CuAAC with a protease,
proteinase K, indeed showed that the diﬀuse labeling and
laddered bands were not protein (Figure 3c). Furthermore,
isolated PA LPS labeled with probes generated a similar pattern
(Figures 3d and S2). The DYN probes are positively charged at
physiological pH, and charge−charge interactions may mediate
binding to the negatively charged phosphates of LPS.
Supportive of this hypothesis, a scrambled Bpa-containing
probe (SCR1, Figure 2b), designed based on the sequence of
the scrambled control peptide SCR, gave a similar LPS-
dominated labeling pattern (Figure 3d).
We initially focused on the Bpa probe DYN1, since probes
with this photogroup gave the strongest labeling and high
pyocyanin induction in PA. Proteins were subject to CuAAC
with biotin-azide, enriched on avidin beads, and digested.
Peptides from control (DMSO vehicle treated) or DYN1
samples were isotopically dimethyl labeled16 for quantiﬁcation,
mixed, and analyzed by gel-free LC-MS/MS. Consistent with
the high level of labeling observed on-gel, large numbers of
proteins were apparently enriched in DYN1 over control
samples, suggestive of high nonspeciﬁc binding or photo-
reactivity (Figure S3).17−19
We next performed chemical proteomic analyses with DYN4
and using a similar workﬂow but label-free MS1 intensity-based
quantiﬁcation (MaxLFQ),20 which enables comparison across
more samples. We included a competition experiment where
bacteria were ﬁrst incubated with 5-fold excess DYN and then
with DYN4, with the aim of diﬀerentiating between genuine
DYN binders over high abundance or false positive hits. DYN4
was more speciﬁc than DYN1 but still gave a large number of
potential hits (Figure S3 and Table S1). Outer membrane
proteins (OMPs) ﬁgured prominently, and biochemical
separation of inner and outer membranes supported this result
(Figure S4). We also observed a surprising enrichment of
ribosomal proteins (Table S1). To check for eﬀects of DYN on
protein synthesis, we treated early log-phase bacteria with DYN
at 10 μM for 2 h and then incubated aliquots for 30 min with
the methionine analogue azidohomoalanine (AHA), which is
incorporated into newly synthesized proteins.21,22 Although
total protein yield was lower for the DYN-treated bacteria due
to reduction in growth, the rate of protein synthesis as
measured by pulsed incorporation of AHA was the same
(Figure S4). Furthermore, a simple aryl azide “minimal”
probe19 labeled proteins in the soluble fraction in a similar
pattern to DYN4 (Figure S4). Together these data suggest that
aryl azide probes exhibit a high degree of nonspeciﬁc binding in
this system. Lack of LPS labeling by DYN4 (Figure S4) also
suggested that this probe is biased in its reactivity. This may be
related to the propensity of aryl azides to undergo ring
expansion upon irradiation.13
Finally, to investigate the protein targets of diazirine probe
DYN5, bacteria were incubated with DYN at varying
concentrations followed by DYN5 (ratios of 1:1, 1:2, and 1:5
of DYN5:DYN) to generate competition data. Enrichment and
label-free proteomics were carried out as before. Analysis of the
data revealed more selective labeling compared to DYN1 and
DYN4 (Figure 4a), as expected given the lower intensity of in-
gel labeling. A subset of enriched proteins was signiﬁcantly
outcompeted at 5-fold excess DYN (Figure S5), and three
proteins were also outcompeted at 2-fold excess DYN (Figure
4b and Table S2). Of these, the protein ParS was alone in being
completely absent from DMSO controls. ParS was also
detected in DYN4 labeling, although only quantiﬁed in two
out of three replicates. We analyzed the competition response
proﬁles (LFQ intensity, raw intensity and sequence coverage)
of all possible hits (Figures S5 and 4c); ParS showed the most
pronounced dose-dependent response.
ParS is a putative membrane sensor kinase and is predicted
to be co-expressed with response regulator ParR in a two-
component system.23 The ParRS system has been linked to the
response of PA to cationic antimicrobial peptides (AMPs).24
AMPs include endogenous host peptides involved in the
Figure 2. Design of photoreactive probes mimicking DYN. (a) Workﬂow for identifying putative DYN protein interactors via chemical proteomics.
Probes are incubated with bacterial cultures, and the cultures are irradiated with UV light, thereby photo-cross-linking the probe to its protein
binding partners. Probes contain a clickable alkyne for ligation to azide-functionalized ﬂuorophores (for visualization by in-gel ﬂuorescence) or biotin
(for aﬃnity enrichment and gel-free LC-MS/MS analysis of tryptic peptides). (b) Sequences of DYN and probes bearing diﬀerent photo-cross-
linkers (all C-terminal amides). Bpa = benzophenone; ArN3 = aryl azide; P(Di) = photoproline (diazirine-bearing proline); K(Di) = diazirine-
modiﬁed lysine; Pra: propargyl-glycine. (c) Structures of the unnatural amino acid residues.
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immune defense against infection and synthetic compounds in
clinical use. Although in many cases their mode of action is
unclear, AMPs often bind to the bacterial membrane and
rapidly kill cells through formation of pores or membrane
disruption.25 Select peptides appear to act via ParRS to induce
adaptive resistance to other AMPsa response where the
bacterial cell activates speciﬁc mechanisms that render it
temporarily more resistant to attack.24 Although DYN only
slightly reduced growth (Figure 1c), it is cationic. Thus, we
selected ParS out of the list of possible hits (Figure 4d) as the
most promising protein for further analysis.
Total Proteome Analysis of DYN-Treated Pseudomo-
nas Reveals an Antimicrobial Peptide-Like Defense
Response. If DYN binds ParS to induce an AMP-like
response in PA, changes in the expression of speciﬁc proteins
and pathways should be detectable. We therefore undertook a
global proteome analysis of bacteria treated with the peptide.
Bacteria were grown for 16 h in the presence of 10 μM DYN (a
concentration resulting in a small drop in growth and a
measurable increase in pyocyanin; Figure S6).
Cells were subsequently lysed, lysates normalized based on
total protein amount, and samples prepared for analysis using
the FASP protocol (ﬁlter-aided sample preparation), which
enables lysis of samples in buﬀers containing high detergent
concentrations to maximize solubilization of membrane
proteins.26 Peptides were analyzed by LC-MS/MS and
quantiﬁed by MaxLFQ.20 Over 3000 proteins were quantiﬁed
in at least three biological replicates, with high reproducibility
(Pearson correlations of 0.96−0.99, Figure S6). We observed a
speciﬁc response, with only 5.5% of proteins signiﬁcantly
aﬀected by DYN treatment (t-test; Figure 5a and Table S3).
Gene ontology analysis suggested that siderophore biosynthesis
and transport, sulfur compound metabolism, localization, and
transport processes were overrepresented among downregu-
lated proteins, indicating moderate changes in iron homeostasis
and uptake (Figure S7). Proteins upregulated by DYN
treatment included those involved in lipid A biosynthesis and
belong to the arn operon (ArnA, B, C, D, and T; Figures 5 and
S8), which is upregulated in response to diverse AMPs. ArnT
adds 4-aminoarabinose to lipid A phosphate groups, reducing
the negative charge of the membrane and promoting resistance
to AMPs.15 The arn operon is under the control of various two-
component systems in PA, including ParRS, PmrAB, and
CprRS.24,27,28 pmrA and pmrB are also upregulated by AMPs,27
and expression levels of these two proteins increased strongly in
response to DYN in our analysis.
Another highly upregulated protein with a known role in
enhanced AMP resistance was SpeE2 (PA4774),29 which,
together with another upregulated product (PA4775), is
predicted to be in the same operon as pmrAB. Another set of
proteins that responded to DYN belong to the resistance-
nodulation-division (RND) family and have known or putative
roles in drug eﬄux. These tripartite complexes consist of an
RND transporter, a periplasmic membrane fusion protein, and
an outer membrane factor and act to pump antibiotics across
the cell membrane.30,31 All proteins from the mexGHI-opmD
operon (PA4205-8) were signiﬁcantly upregulated, as were
MexX and MexY (PA2018-19; Table S3). In contrast, the porin
OprD, annotated as a basic amino acid, basic peptide, and
imipenem outer membrane transporter, was downregulated.
Interestingly, the ParRS system has been previously linked to
these changes.32
Another virulence-related protein, PA-I galactophilic lectin
(LecA) was strongly upregulated in our data. LecA is a
cytotoxic lectin and adhesion molecule implicated in bioﬁlm
formation33 and induced in response to another host signal,
interferon-γ.8 The data described above were collected
incubation of DYN throughout growth until stationary phase.
To explore the eﬀects of transient DYN exposure, bacteria were
grown to early exponential phase and then incubated with a
slightly lower concentration of 5 μM DYN (to limit the mild
inhibition of growth that DYN induces), and the global
Figure 3. Photoaﬃnity labeling in live bacteria. (a) Determination of
growth (OD, gray) and PYO (blue) induction by probes. Error bars
show standard deviation from 3 biological replicates. (b) Gel-based
analysis after photolabeling with probes (DYN5, 9, 4, and 3; see Figure
2) in live PA. Probes were incubated at 5 μM. Irradiation with UV was
performed as indicated; after lysis and separation into soluble (PBS)
and insoluble fractions, proteins were subject to CuAAC with
rhodamine-azide (RhN3), precipitated with acetone, separated by
gel, and imaged for ﬂuorescence. Insoluble fraction shown here. (c)
Analysis of probe labeling of bacterial lipopolysaccharide (LPS).
Bacteria were labeled with DYN1 or DYN5 and lysed in 0.2% TX100
in PBS. Following CuAAC with RhN3 and precipitation, samples were
resuspended, split into two portions, and treated with proteinase K
(Prot.K) or buﬀer (control) to digest proteinaceous material. Samples
were separated on SDS PAGE, and gels ﬂuorescent scanned. (d) Left:
probe DYN1 labeling of puriﬁed LPS. Right: Scrambled Bpa probe
SCR1 labeling of bacteria (as for c). See full gels and Coomassie
staining in Figure S2.
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proteome analyzed (Table S4). Only 0.75% of proteins showed
a signiﬁcant response under these conditions: Again, proteins in
the arn and pmrAB operons were the most prominent
upregulated hits (Figure 5b). Thus, arn and pmrAB
upregulation is a rapid, direct response to DYN under diﬀerent
growth stages.
In all analyses, ParR and ParS proteins themselves were
unaﬀected by DYN treatment; however, this is not inconsistent
with their role as mediators since a previous study by
Fernańdez et al. reported that the AMP indolicidin had no
eﬀect on parRS expression, although this peptide triggered
responses via parRS. We compared our data set to the
microarray transcriptome data of Fernańdez et al.24 Proteins in
the arn and pmr operons, signiﬁcantly upregulated by DYN
treatment in our analysis, were indeed induced by indolicidin
treatment in wild-type relative to a parR mutant (Table S6).
ParS Mediates the DYN-Induced Phenotype. We
hypothesized that of the possible DYN targets (Figure 4d),
ParS was most likely responsible for the AMP-defense
phenotype. To test this hypothesis more directly, a PAO1
parS transposon mutant was obtained (PA Two-Allele Library,
University of Washington), validated by PCR (Figure S9), and
assayed for response to DYN. Both this and a parR mutant
were dramatically more susceptible to DYN-induced toxicity
than the original wild-type (wt) strain, and we did not observe
any pyocyanin production in response to the peptide at
nontoxic concentrations (Figure S9). Using a low DYN
concentration of 1 μM to minimize eﬀects on growth, we
repeated the global proteome analysis of the parS mutant or wt
PA treated with DYN for 16 h (Figure S6 and Table S5). Even
at this low concentration, there was strong upregulation of Arn
proteins and PmrA & B in wt bacteria, while cells lacking ParS
showed no signiﬁcant response at all (Figure 6b). Although
there are diﬀerences between the parS mutant and wt strain
proteomes, most proteins altered by DYN treatment in the wt
were expressed at comparable levels (Figure S10). Further-
more, although parR and parS mutants were more susceptible
to DYN treatment (Figure 6b), other strains from the library,
such as a strain mutant in the unrelated response regulator
phoP, showed a similar growth and phenotypic response to the
wt (Figure S9). Together these data strongly link ParS to the
AMP-defense response of Pseudomonas to DYN.
■ DISCUSSION
Here we use chemical probes to identify a membrane sensor
kinase, ParS, as a binding partner of the human peptide
dynorphin and the mediator of a highly speciﬁc bacterial
defense response.
Figure 4. Chemical proteomics with diazirine probe DYN5 reveals ParS as a potential target. Bacteria were incubated with 3 μM DYN5, or DYN5
plus increasing concentrations of DYN (1, 2, or 5-fold), or DMSO control, irradiated, lysed, proteins ligated by CuAAC to biotin-N3, enriched on
avidin beads, digested by trypsin, and peptides analyzed by LC-MS/MS. Three independent biological replicate labeling experiments were performed
on diﬀerent days. Data were analyzed by MaxLFQ, ﬁltered to retain only proteins identiﬁed by multiple peptides, and quantiﬁed in 2/3 biological
replicates, and missing values were imputed to mimic noise. Two-sample permutation-corrected t-tests with FDR (false discovery rate) control were
performed to compare samples. (a) Volcano plot depicting enrichment and signiﬁcance of enrichment in chemical proteomics experiments with 3
μM DYN5. In red: proteins shown to be outcompeted by 5× excess DYN (see Figure S5); n = 3 biological replicates. (b) Volcano plot showing
results of competition between DYN5 and 2× excess DYN. In blue: proteins enriched over DMSO controls (see a). (c) Proﬁle plots of potential hits
(raw MS1 intensity). * = value of zero in DMSO control for these proteins. Proteins selected showed a dose−response (see Figure S5), signiﬁcant
enrichment over DMSO controls, and signiﬁcant out-competition by DYN. FruR, PA33440, and PdxY did not show a consistent dose−response. (d)
The most promising hits based on competition and enrichment and their putative roles, see Table S2.
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Dynorphin(1−17) and the shorter (1−13) analogue (DYN)
both induced production of the virulence factor pyocyanin.
Interestingly this phenotype was highly medium dependent,
indicating that PA integrates multiple environmental signals in
its response to these compounds. Pyocyanin induction was also
peptide sequence dependent; however, binding of DYN-based
photoaﬃnity probes to the LPS was subsequently shown to be
sequence independent, suggesting that LPS interaction is not
responsible for induction of virulence but may be important for
initial charge-mediated coordination with the cell membrane.
Photoaﬃnity probes with diﬀerent photoreactive groups
exhibited very distinct proﬁles, and the lack of speciﬁcity
exhibited by both benzophenones and aryl azides, as noted
recently by us and others,17,19 led us to focus on diazirine-
containing probes. We identiﬁed the membrane protein ParS,
the sensing partner of a two-component response system, as a
promising hit.
Subsequent in-depth global proteome analyses of bacteria
treated with DYN at diﬀerent growth stages revealed a highly
speciﬁc, parS-dependent, response: A dramatic increase in the
levels of proteins that boost membrane defense mechanisms
against cationic peptides. Upregulated proteins included those
in the arn operon that modify lipid A, reducing the negative
charge of the membrane and thereby increasing AMP
resistance. Such modiﬁcations also alter outer membrane
permeability and host immune recognition of LPS and are
common in clinical isolates of PA from cystic ﬁbrosis patients.34
These data are consistent with previous reports of parRS-
dependent arn upregulation and adaptive AMP resistance.24
Previous work showed that ParRS and a second two-
component system CprRS mediate the response to diverse
AMPs in PA in a peptide-dependent manner.28 CprRS was not
detected in our analyses, suggesting that it is not involved in
DYN-dependent signaling. Interestingly, DYN is only weakly
toxic but induces strong upregulation of defense pathways,
consistent with previous data indicating that the signaling and
growth inhibition functions of AMPs are not directly
coupled.24,27,28 More work is needed to understand the
structure−activity relationships of AMP signaling and the
exact binding site of the peptides, but it is tempting to speculate
that DYN binds at the predicted negatively charged periplasmic
loops of ParS, in a similar manner to peptide binding to sensor
Figure 5. Global proteomics reveals speciﬁc changes in response to DYN. (a) Volcano plot visualization of global proteomics experiment “Stat.10”.
PA was grown in the presence of DYN at 10 μM for 16 h until stationary phase. Bacteria were harvested and lysed and samples prepared by FASP for
LC-MS/MS. Quantiﬁcation was carried out with MaxLFQ; n = 5 (biological replicates). After ﬁltering to discard proteins not identiﬁed in at least
four replicates, missing values were imputed, and a two-sample t-test (permutation-based, FDR 0.01, s0 1) carried out to compare DMSO and DYN
treated samples. Proteins of particular interest are labeled and color-coded by putative function/pathway, see also Table S3. (b) Global proteomics−
exponential phase, data set “Exp.5”. PA was grown to OD 0.2−0.3 then incubated with DYN at 5 μM for 2 h during exponential growth. Samples
were analyzed as above; n = 3 (replicates grown from independent starter cultures). Only proteins identiﬁed in at least duplicate were used in
analysis. Missing values were imputed (downshift 1.8, width 0.3), and a two-sample t-test (permutation-based, FDR 0.05, s0 1) carried out to
compare DMSO and DYN treated samples, see also Table S4. (c) Cytoscape analysis of upregulated proteins (from a; see also Figure S8). Edges
between nodes represent predicted functional or physical interactions. Analysis of downregulated proteins is shown in Figure S7.
Journal of the American Chemical Society Article
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PhoQ in Salmonella.35 The mechanism of mild bacterial growth
inhibition by DYN also remains to be explored, but may be due
to stress induced by membrane binding.
Treatment of PA with Dyn-A has been previously linked to
the PQS (Pseudomonas Quinolone Signal) quorum sensing
(QS) system.4 AMPs, such as colistin, also induce expression of
QS genes,36 and ParRS has been linked to modest changes in
QS pathways in PA.37 However, we observed no upregulation
of any QS proteins in our proteomic analyses. This could be
due to the timing of analysis, or diﬀerences in the culture
medium, which is a key determinate in the phenotypic
response. Our proteomic data also do not readily explain the
increase in pyocyanin production observed in response to
DYN; of all the proteins involved in the synthesis of this toxin,
only PhzB2 was upregulated. Again, this could reﬂect timing of
analysis. How ParRS signaling may be linked to the circuitry for
enhanced pyocyanin production is unclear, and it is possible
that other sensors and pathways are involved in this aspect of
the response. The other chemical proteomics hits identiﬁed
here (Figure 4d; e.g., putative sensor/response regulator
PA1243) are interesting starting points for further study.
We also observed DYN-induced upregulation of drug eﬄux
pumps. A previous study showed that, unlike wt bacteria, a
parRS mutant did not upregulate MexXY and downregulate the
porin OprD in response to AMPs and that spontaneous
mutants in parR and S had heightened intrinsic resistance to
diverse antibiotics.32 This may be clinically relevant since the
AMP colistin and other antibiotics are given sequentially to
cystic ﬁbrosis patients.32,38 The present study thus adds to the
increasing body of evidence linking virulence and antibiotic
resistance in Pseudomonas and suggests that host factors can
trigger a multiresistant phenotype in this pathogen.
■ CONCLUSION
In summary, we reveal that a human opioid peptide induces a
speciﬁc defense mechanism in P. aeruginosa (PA) via direct
binding of the sensor ParS. We provide strong evidence that the
antimicrobial peptide (AMP) response is mediated by ParS.
Concentrations of up to ∼0.4 μM Dyn-A have been reported in
the PA-infected, injured gut4in the same range as DYN
concentrations that induced a AMP responseindicating that
this eﬀect could be biologically relevant in vivo. Our data thus
supports the intriguing possibility that Pseudomonas can
speciﬁcally recognize human stress hormones and initiate
mechanisms to defend itself against the hostile environment of
the host. This work highlights ParS as a promising drug target
for blocking virulence induction and for sensitizing bacteria to
antimicrobial therapies.
Figure 6. . ParS mediates the AMP-response induced by DYN treatment. (a) Volcano plot visualization of Stat.1 data set (wt or parS mutant bacteria
grown for 16 h in the presence of 1 μM DYN or DMSO control); n = 3 replicates (grown from separate starter cultures on the same day). Bacteria
were harvested, lysed, and samples prepared by FASP for LC-MS/MS. Quantiﬁcation was carried out with MaxLFQ. After ﬁltering to discard
proteins not identiﬁed in at least two replicates, missing values were imputed (downshift 1.8, width 0.3), and a two-sample t-test (permutation-based,
FDR 0.05, s0 1) carried out to compare DMSO and DYN treated samples for each strain. No signiﬁcant hits were obtained in the parS mutant, see
also Table S5. The wt and mutant proteomes are compared in Figure S10. (b) parS and parR transposon mutants are more susceptible to treatment
with DYN. Error bars show standard deviation from technical duplicates. Pyocyanin production in these mutants and others is shown in Figure S9.
(c) Proposed model for DYN signaling via ParS to promote membrane defense mechanisms and induce virulence. DYN interacts with ParS sensor
kinase, presumably triggering phosphorylation of the response regulator ParR and transcription of proteins in the pmrAB and arn operons. Proteins
from these operons are involved in the antimicrobial peptide-liked response, speciﬁcally modifying the structure of LPS lipid A in the case of ArnT.
Eﬄux pumps are also upregulated. Thus, ParS signaling triggers bacterial defense against antimicrobial peptides and antibiotics. The link to virulence
expression (e.g., pyocyanin induction and upregulation of bioﬁlm-related protein LecA) is yet to be elucidated.
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mass spectrometry assistance, Mona Wolﬀ for technical
assistance, and Angela Weigert Muños, Mert Malay, and
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